Apimeds Pharmaceuticals US (APUS) Market Cap (2025 - 2026)
Apimeds Pharmaceuticals US (APUS) market cap from May 9, 2025 to Jul 20, 2026. The current Apimeds Pharmaceuticals US (APUS) market cap is $7.99M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Apimeds Pharmaceuticals US (APUS) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +584.75% |
Annual Market Cap change of Apimeds Pharmaceuticals US (APUS)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $7.99M | -61.28% |
| 2025 | $21M | N/A |
Comparison Apimeds Pharmaceuticals US (APUS) market cap with competitors
Apimeds Pharmaceuticals US (APUS) market cap is $7.99M.